Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
EXEL | EXELIXIS, INC. | Aftab Dana | CSO/EVP Disc & Trans Research | Jan 16, 2025 | Option Exercise | $37.27 | 22,570 | 841,184 | 567,643 | Jan 17, 2025, 09:45 PM | |
EXEL | EXELIXIS, INC. | Aftab Dana | CSO/EVP Disc & Trans Research | Nov 15, 2024 | Option Exercise | $35.05 | 12,838 | 449,972 | 486,107 | Nov 19, 2024, 08:02 PM | |
EXEL | EXELIXIS, INC. | Aftab Dana | CSO/EVP Disc & Trans Research | Nov 05, 2024 | Option Exercise | $18.80 | 96,986 | 1,823,337 | 595,931 | Nov 07, 2024, 07:44 PM | |
EXEL | EXELIXIS, INC. | Aftab Dana | CSO/EVP Disc & Trans Research | Nov 05, 2024 | Sale | $35.00 | 96,986 | 3,394,510 | 498,945 | Nov 07, 2024, 07:44 PM | |
EXEL | EXELIXIS, INC. | Aftab Dana | CSO/EVP Disc & Trans Research | Oct 30, 2024 | Sale | $31.40 | 1,162 | 36,487 | 498,945 | Nov 01, 2024, 06:43 PM | |
EXEL | EXELIXIS, INC. | Aftab Dana | CSO/EVP Disc & Trans Research | Aug 12, 2024 | Sale | $27.06 | 20,883 | 565,094 | 500,107 | Aug 14, 2024, 07:12 PM | |
EXEL | EXELIXIS, INC. | Aftab Dana | CSO/EVP Disc & Trans Research | Aug 07, 2024 | Option Exercise | $24.41 | 95,000 | 2,318,950 | 615,990 | Aug 09, 2024, 07:32 PM | |
EXEL | EXELIXIS, INC. | Aftab Dana | CSO/EVP Disc & Trans Research | Aug 07, 2024 | Sale | $25.00 | 95,000 | 2,375,000 | 520,990 | Aug 09, 2024, 07:32 PM | |
EXEL | EXELIXIS, INC. | Aftab Dana | CSO/EVP Disc & Trans Research | May 15, 2024 | Option Exercise | $20.99 | 22,605 | 474,479 | 537,186 | May 17, 2024, 07:58 PM | |
EXEL | EXELIXIS, INC. | Aftab Dana | CSO/EVP Disc & Trans Research | Feb 15, 2024 | Option Exercise | $20.39 | 10,630 | 216,746 | 479,031 | Feb 16, 2024, 07:21 PM | |
EXEL | EXELIXIS, INC. | Aftab Dana | CSO/EVP Disc & Trans Research | Jan 11, 2024 | Option Exercise | $22.86 | 11,606 | 265,313 | 489,661 | Jan 16, 2024, 08:50 PM | |
EXEL | EXELIXIS, INC. | Aftab Dana | CSO/EVP Disc & Trans Research | Sep 06, 2023 | Option Exercise | $22.27 | 12,560 | 279,711 | 438,043 | Sep 08, 2023, 09:25 PM | |
EXEL | EXELIXIS, INC. | Aftab Dana | CSO/EVP Disc & Trans Research | Aug 30, 2023 | Sale | $22.47 | 4,600 | 103,362 | 399,943 | Sep 01, 2023, 08:15 PM | |
EXEL | EXELIXIS, INC. | Aftab Dana | CSO/EVP Disc & Trans Research | Aug 15, 2023 | Option Exercise | $21.51 | 6,280 | 135,083 | 404,543 | Aug 17, 2023, 08:14 PM | |
EXEL | EXELIXIS, INC. | Aftab Dana | CSO/EVP Disc & Trans Research | May 15, 2023 | Option Exercise | $19.18 | 10,488 | 201,160 | 416,938 | May 17, 2023, 08:12 PM | |
EXEL | EXELIXIS, INC. | Aftab Dana | CSO/EVP Disc & Trans Research | Feb 27, 2023 | Option Exercise | $14.74 | 10 | 147 | 351,482 | Mar 01, 2023, 07:56 PM | |
EXEL | EXELIXIS, INC. | Aftab Dana | CSO/EVP Disc & Trans Research | Feb 27, 2023 | Sale | $17.50 | 10 | 175 | 351,472 | Mar 01, 2023, 07:56 PM | |
EXEL | EXELIXIS, INC. | Aftab Dana | CSO/EVP Disc & Trans Research | Feb 28, 2023 | Option Exercise | $14.74 | 82,490 | 1,215,903 | 433,962 | Mar 01, 2023, 07:56 PM | |
EXEL | EXELIXIS, INC. | Aftab Dana | CSO/EVP Disc & Trans Research | Feb 28, 2023 | Sale | $17.50 | 82,490 | 1,443,575 | 351,472 | Mar 01, 2023, 07:56 PM | |
EXEL | EXELIXIS, INC. | Aftab Dana | CSO/EVP Disc & Trans Research | Feb 15, 2023 | Option Exercise | $18.08 | 1,529 | 27,644 | 351,472 | Feb 17, 2023, 09:39 PM |